Express News | The opening of the tenth batch of national Pharmaceutical centralized purchasing has prompted nearly 30 listed companies to announce their products are likely to be selected after the market close.

BreakingsDec 13 21:24

Express News | Guangxi Wuzhou Zhongheng Group: The holding subsidiary Chongqing Lummy Pharmaceutical's product Nimodipine Injection is planned to be selected for the tenth batch of national centralized pharmaceutical procurement.

BreakingsDec 13 18:35

Express News | Guangxi Wuzhou Zhongheng Group: plans to transfer 23.43% of shares of Chongqing Lummy Pharmaceutical through public solicitation of transferees, approved by the Guangxi State-owned Assets Supervision and Administration Commission.

BreakingsDec 12 22:57

Guangxi Wuzhou Zhongheng Group's Two Drugs Gets Added to Medical Insurance Catalog

MT NewswiresDec 2 16:24

Guangxi Wuzhou Zhongheng Group (600252.SH): The products of the controlling subsidiary are included in the national medical insurance catalog.

GZ11月29日中恒集团(600252.SH) announced that its holding subsidiary, Chongqing Lummy Pharmaceutical Co., Ltd. (referred to as chongqing lummy pharmaceutical), has newly included the products Nimodipine Injection and Omeprazole Enteric-coated Tablets into the Medical Insurance Catalogue (2024), except for the newly included products mentioned above, the products included in the Medical Insurance Catalogue (2024) remain unchanged from the Medical Insurance Catalogue (2023).

Gelonghui FinanceNov 29 17:54

Wuzhou Zhongheng to Transfer Stake in Lummy Pharma

MT NewswiresNov 27 15:32